Literature DB >> 29406570

New revelations from an old receptor: Immunoregulatory functions of the inhibitory Fc gamma receptor, FcγRIIB (CD32B).

Ali Roghanian1,2, Richard J Stopforth1, Lekh N Dahal1, Mark S Cragg1.   

Abstract

The Fc gamma receptor IIB (FcγRIIB/CD32B) was generated million years ago during evolution. It is the sole inhibitory receptor for IgG, and has long been associated with the regulation of humoral immunity and innate immune homeostasis. However, new and surprising functions of FcγRIIB are emerging. In particular, FcγRIIB has been shown to perform unexpected activatory roles in both immune-signaling and monoclonal antibody (mAb) immunotherapy. Furthermore, although ITIM signaling is an integral part of FcγRIIB regulatory activity, it is now clear that inhibition/activation of immune responses can occur independently of the ITIM. In light of these new findings, we present an overview of the established and noncanonical functions of FcγRIIB and discuss how this knowledge might be exploited therapeutically. ©2018 Society for Leukocyte Biology.

Entities:  

Year:  2018        PMID: 29406570     DOI: 10.1002/JLB.2MIR0917-354R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

1.  Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression.

Authors:  Ali Roghanian; Guangan Hu; Christopher Fraser; Maneesh Singh; Russell B Foxall; Matthew J Meyer; Emma Lees; Heather Huet; Martin J Glennie; Stephen A Beers; Sean H Lim; Margaret Ashton-Key; Stephen M Thirdborough; Mark S Cragg; Jianzhu Chen
Journal:  Cancer Immunol Res       Date:  2019-08-26       Impact factor: 11.151

Review 2.  Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies.

Authors:  Juan J Mata-Molanes; Joseba Rebollo-Liceaga; Elena Mª Martínez-Navarro; Ramón González Manzano; Antonio Brugarolas; Manel Juan; Manuel Sureda
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

Review 3.  Inside-Out Control of Fc-Receptors.

Authors:  Leo Koenderman
Journal:  Front Immunol       Date:  2019-03-21       Impact factor: 7.561

4.  Overexpression of FcγRIIB regulates downstream protein phosphorylation and suppresses B cell activation to ameliorate systemic lupus erythematosus.

Authors:  Linlin Sheng; Xiuqin Cao; Shuhong Chi; Jing Wu; Huihui Xing; Huiyu Liu; Zhiwei Yang
Journal:  Int J Mol Med       Date:  2020-08-07       Impact factor: 4.101

5.  Lipopolysaccharide-Enhanced Responses against Aryl Hydrocarbon Receptor in FcgRIIb-Deficient Macrophages, a Profound Impact of an Environmental Toxin on a Lupus-Like Mouse Model.

Authors:  Kanyarat Udompornpitak; Thansita Bhunyakarnjanarat; Awirut Charoensappakit; Cong Phi Dang; Wilasinee Saisorn; Asada Leelahavanichkul
Journal:  Int J Mol Sci       Date:  2021-04-18       Impact factor: 5.923

Review 6.  Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies.

Authors:  Nisha Kumari; Seung Hong Choi
Journal:  J Exp Clin Cancer Res       Date:  2022-02-19

7.  The secreted protein Cowpox Virus 14 contributes to viral virulence and immune evasion by engaging Fc-gamma-receptors.

Authors:  Ravi F Iyer; David M Edwards; Philipp Kolb; Hans-Peter Raué; Chris A Nelson; Megan L Epperson; Mark K Slifka; Jeffrey C Nolz; Hartmut Hengel; Daved H Fremont; Klaus Früh
Journal:  PLoS Pathog       Date:  2022-09-19       Impact factor: 7.464

8.  Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells.

Authors:  Melissa Newling; Willianne Hoepel; Lisa T C Vogelpoel; Marieke H Heineke; Johan A van Burgsteden; Esther W M Taanman-Kueter; Dirk Eggink; Taco W Kuijpers; Tim Beaumont; Marjolein van Egmond; Martien L Kapsenberg; Dominique L P Baeten; Jeroen den Dunnen; Esther C de Jong
Journal:  Eur J Immunol       Date:  2018-09-14       Impact factor: 5.532

9.  FcγRIIB is a T cell checkpoint in antitumor immunity.

Authors:  Clara R Farley; Anna B Morris; Marvi Tariq; Kelsey B Bennion; Sayalee Potdar; Ragini Kudchadkar; Michael C Lowe; Mandy L Ford
Journal:  JCI Insight       Date:  2021-02-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.